Abrir sesión | Regístrese | ¿Olvidó su contraseña? | Contacto | English |
Email: Clave:

Medwave se preocupa por su privacidad y la seguridad de sus datos personales.
Para poder enviarle a su dirección de correo electrónico su contraseña, es necesario que ingrese su e-mail.


Reporte de caso
Medwave 2019;19(4):e7641 doi: 10.5867/medwave.2019.04.7641
Tratamiento artroscópico de sinovitis villonodular pigmentada de tobillo: reporte de caso y revisión de literatura
Arthroscopic treatment of pigmented villonodular synovitis of the ankle: a clinical case report and review
Soledad Salas González, Tomás Urrutia Jarpa, Jorge Filippi
Referencias | Descargar PDF |
Para Descargar PDF debe Abrir sesión.
Imprimir | A(+) A(-) | Lectura fácil

Palabras clave: synovitis, pigmented villonodular, arthritis

Abstract

Pigmented villonodular synovitis is a benign tumor of synovial tissue with a very low incidence. Ankle location is even less frequent. Early diagnosis and management are required to avoid irreversible functional and mechanical sequelae. The clinical presentation starts with edema or joint effusion and may progress with pain and advanced joint degenerative changes. Pigmented villonodular synovitis can be focal or diffuse, the latter being the type with the worst prognosis. When suspected, magnetic resonance imaging is performed, and the diagnosis confirmed with a biopsy in which synovial inflammatory tissue with hemosiderin deposits is observed. An open or arthroscopic synovectomy is preferred over surgical management. Recurrence is up to 40%, which is why biological coadjutant therapies and radiotherapy are described. This article presents the case of a 30-year-old man who presented with pain and claudication of the left ankle; the imaging study findings were compatible with diffuse pigmented villonodular synovitis of the ankle with extension to the subtalar joint, leading to arthroscopy for treatment and biopsy. This case report illustrates the results with this patient and a literature review of the subject.


 

Only Spanish version is available for this Case report.

 

Licencia Creative Commons Esta obra de Medwave está bajo una licencia Creative Commons Atribución-NoComercial 3.0 Unported. Esta licencia permite el uso, distribución y reproducción del artículo en cualquier medio, siempre y cuando se otorgue el crédito correspondiente al autor del artículo y al medio en que se publica, en este caso, Medwave.

 

Pigmented villonodular synovitis is a benign tumor of synovial tissue with a very low incidence. Ankle location is even less frequent. Early diagnosis and management are required to avoid irreversible functional and mechanical sequelae. The clinical presentation starts with edema or joint effusion and may progress with pain and advanced joint degenerative changes. Pigmented villonodular synovitis can be focal or diffuse, the latter being the type with the worst prognosis. When suspected, magnetic resonance imaging is performed, and the diagnosis confirmed with a biopsy in which synovial inflammatory tissue with hemosiderin deposits is observed. An open or arthroscopic synovectomy is preferred over surgical management. Recurrence is up to 40%, which is why biological coadjutant therapies and radiotherapy are described. This article presents the case of a 30-year-old man who presented with pain and claudication of the left ankle; the imaging study findings were compatible with diffuse pigmented villonodular synovitis of the ankle with extension to the subtalar joint, leading to arthroscopy for treatment and biopsy. This case report illustrates the results with this patient and a literature review of the subject.

Autores: Soledad Salas González[1], Tomás Urrutia Jarpa[2], Jorge Filippi[2,3]

Filiación:
[1] Escuela de Medicina. Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile
[2] Departamento de Ortopedia y Traumatologia, Facultad de Medicin, Pontificia Universidad Catolica de Chile, Santiago, Chile.
[3] Equipo Cirugía de Tobillo y Pie, Clínica Las Condes, Santiago Chile

E-mail: jfilippi@clinicalascondes.cl

Correspondencia a:
[1] Departamento de Ortopedia y Traumatología
Pontificia Universidad Católica de Chile
Diagonal Paraguay 362, 3er piso
Cod. Postal: 8330077

Citación: Salas González S, Urrutia Jarpa T, Filippi J. Arthroscopic treatment of pigmented villonodular synovitis of the ankle: a clinical case report and review. Medwave 2019;19(4):e7641 doi: 10.5867/medwave.2019.04.7641

Fecha de envío: 12/12/2018

Fecha de aceptación: 2/5/2019

Fecha de publicación: 27/5/2019

Origen: no solicitado

Tipo de revisión: con revisión por dos pares revisores externos, a doble ciego

Ficha PubMed

Comentarios (0)

Nos complace que usted tenga interés en comentar uno de nuestros artículos. Su comentario será publicado inmediatamente. No obstante, Medwave se reserva el derecho a eliminarlo posteriormente si la dirección editorial considera que su comentario es: ofensivo en algún sentido, irrelevante, trivial, contiene errores de lenguaje, contiene arengas políticas, obedece a fines comerciales, contiene datos de alguna persona en particular, o sugiere cambios en el manejo de pacientes que no hayan sido publicados previamente en alguna revista con revisión por pares.

Aún no hay comentarios en este artículo.


Para comentar debe iniciar sesión

Medwave publica las vistas HTML y descargas PDF por artículo, junto con otras métricas de redes sociales.

Se puede producir un retraso de 48 horas en la actualización de las estadísticas.

  1. Cattelan M, Bonnomet F, Bierry G, Di Marco A, Brinkert D, Adam P, et al. Villonodular synovitis of the ankle. Analysis of the risk of recurrence. Orthop Traumatol Surges. 2016 Sep;102(5):639-44. | CrossRef | PubMed |
  2. Stephan SR, Shallop B, Lackman R, Kim TW, Mulcahey MK. Pigmented Villonodular Synovitis: A Comprehensive Review and Proposed Treatment Algorithm. JBJS Rev. 2016 Jul 19;4(7). pii: 01874474-201607000-00005. | CrossRef | PubMed |
  3. Gouin F, Noailles T. Localized and diffuse forms of tenosynovial giant cell tumor (formerly giant cell tumor of the tendon sheath and pigmented villonodular synovitis). Orthop Traumatol Surg Res. 2017 Feb;103(1S):S91-S97. | CrossRef | PubMed |
  4. Stevenson JD, Jaiswal A, Gregory JJ, Mangham DC, Cribb G, Cool P. Diffuse pigmented villonodular synovitis (diffuse-type giant cell tumour) of the foot and ankle. Bone Joint J. 2013 Mar;95-B(3):384-90. | CrossRef | PubMed |
  5. Cheng XG, You YH, Liu W, Zhao T, Qu H. MRI features of pigmented villonodular synovitis (PVNS). Clin Rheumatol. 2004 Feb;23(1):31-4. Epub 2004 Jan 9. | PubMed |
  6. Garner HW, Ortiguera CJ, Nakhleh RE. Pigmented villonodular synovitis. Radiographics. 2008 Sep-Oct;28(5):1519-23. | CrossRef | PubMed |
  7. Guo Q, Shi W, Jiao C, Xie X, Jiang D, Hu Y. Results and recurrence of pigmented villonodular synovitis of the ankle: does diffuse PVNS with extra-articular extension tend to recur more often? Knee Surg Sports Traumatol Arthrosc. 2018 Oct;26(10):3118-3123. | CrossRef | PubMed |
  8. Kubat O, Bojanić I, Smoljanović T. Localized pigmented villonodular synovitis of the ankle: Expect the unexpected. Foot Ankle Surg. 2017 Mar;23(1):68-72. | CrossRef | PubMed |
  9. Aurégan J, Klouche S, Bohu Y, Lefèvre N, Herman S, Hardy P, et al. Treatment of Pigmented Villonodular Synovitis of the Knee. Arthrosc J Arthrosc Relat Surg. 2014;30(10):1327-41. | CrossRef | PubMed |
  10. Chin KR, Brick GW. Extraarticular pigmented villonodular synovitis: a cause for failed knee arthroscopy. Clin Orthop Relat Res. 2002 Nov;(404):330-8. | PubMed |
  11. Korim MT, Clarke DR, Allen PE, Richards CJ, Ashford RU. Clinical and oncological outcomes after surgical excision of pigmented villonodular synovitis at the foot and ankle. Foot Ankle Surg. 2014 Jun;20(2):130-4. | CrossRef | PubMed |
  12. Li X, Xu Y, Zhu Y, Xu X. Surgical treatment for diffused-type giant cell tumor (pigmented villonodular synovitis) about the ankle joint. BMC Musculoskelet Disord. 2017 Nov 14;18(1):450. | CrossRef | PubMed |
  13. Mollon B, Lee A, Busse JW, Griffin AM, Ferguson PC, Wunder JS, et al. The effect of surgical synovectomy and radiotherapy on the rate of recurrence of pigmented villonodular synovitis of the knee: an individual patient meta-analysis. Bone Joint J. 2015 Apr;97-B(4):550-7. | CrossRef | PubMed |
  14. Bickels J, Isaakov J, Kollender Y, Meller I. Unacceptable complications following intra-articular injection of yttrium 90 in the ankle joint for diffuse pigmented villonodular synovitis. J Bone Joint Surg Am. 2008 Feb;90(2):326-8. | CrossRef | PubMed |
  15. Brahmi M, Vinceneux A, Cassier PA. Current Systemic Treatment Options for Tenosynovial Giant Cell Tumor/Pigmented Villonodular Synovitis: Targeting the CSF1/CSF1R Axis. Curr Treat Options Oncol. 2016 Feb;17(2):10. | CrossRef | PubMed |
  16. Peyraud F, Cousin S, Italiano A. CSF-1R Inhibitor Development: Current Clinical Status. Curr Oncol Rep. 2017 Sep 5;19(11):70. | CrossRef | PubMed |
  17. Castro Corredor D, Bravo WRM, Huaranga MAR, Mateos Rodríguez JJ, Rebollo Giménez AI, Anino Fernández J, et al. Radioisotope Synoviorthesis in the Control of Refractory Synovitis in Castilla-La Mancha. A 10-year Experience. Reumatol Clin. 2019 Jan 25. pii: S1699-258X(18)30238-9. | CrossRef | PubMed |
Cattelan M, Bonnomet F, Bierry G, Di Marco A, Brinkert D, Adam P, et al. Villonodular synovitis of the ankle. Analysis of the risk of recurrence. Orthop Traumatol Surges. 2016 Sep;102(5):639-44. | CrossRef | PubMed |

Stephan SR, Shallop B, Lackman R, Kim TW, Mulcahey MK. Pigmented Villonodular Synovitis: A Comprehensive Review and Proposed Treatment Algorithm. JBJS Rev. 2016 Jul 19;4(7). pii: 01874474-201607000-00005. | CrossRef | PubMed |

Gouin F, Noailles T. Localized and diffuse forms of tenosynovial giant cell tumor (formerly giant cell tumor of the tendon sheath and pigmented villonodular synovitis). Orthop Traumatol Surg Res. 2017 Feb;103(1S):S91-S97. | CrossRef | PubMed |

Stevenson JD, Jaiswal A, Gregory JJ, Mangham DC, Cribb G, Cool P. Diffuse pigmented villonodular synovitis (diffuse-type giant cell tumour) of the foot and ankle. Bone Joint J. 2013 Mar;95-B(3):384-90. | CrossRef | PubMed |

Cheng XG, You YH, Liu W, Zhao T, Qu H. MRI features of pigmented villonodular synovitis (PVNS). Clin Rheumatol. 2004 Feb;23(1):31-4. Epub 2004 Jan 9. | PubMed |

Garner HW, Ortiguera CJ, Nakhleh RE. Pigmented villonodular synovitis. Radiographics. 2008 Sep-Oct;28(5):1519-23. | CrossRef | PubMed |

Guo Q, Shi W, Jiao C, Xie X, Jiang D, Hu Y. Results and recurrence of pigmented villonodular synovitis of the ankle: does diffuse PVNS with extra-articular extension tend to recur more often? Knee Surg Sports Traumatol Arthrosc. 2018 Oct;26(10):3118-3123. | CrossRef | PubMed |

Kubat O, Bojanić I, Smoljanović T. Localized pigmented villonodular synovitis of the ankle: Expect the unexpected. Foot Ankle Surg. 2017 Mar;23(1):68-72. | CrossRef | PubMed |

Aurégan J, Klouche S, Bohu Y, Lefèvre N, Herman S, Hardy P, et al. Treatment of Pigmented Villonodular Synovitis of the Knee. Arthrosc J Arthrosc Relat Surg. 2014;30(10):1327-41. | CrossRef | PubMed |

Chin KR, Brick GW. Extraarticular pigmented villonodular synovitis: a cause for failed knee arthroscopy. Clin Orthop Relat Res. 2002 Nov;(404):330-8. | PubMed |

Korim MT, Clarke DR, Allen PE, Richards CJ, Ashford RU. Clinical and oncological outcomes after surgical excision of pigmented villonodular synovitis at the foot and ankle. Foot Ankle Surg. 2014 Jun;20(2):130-4. | CrossRef | PubMed |

Li X, Xu Y, Zhu Y, Xu X. Surgical treatment for diffused-type giant cell tumor (pigmented villonodular synovitis) about the ankle joint. BMC Musculoskelet Disord. 2017 Nov 14;18(1):450. | CrossRef | PubMed |

Mollon B, Lee A, Busse JW, Griffin AM, Ferguson PC, Wunder JS, et al. The effect of surgical synovectomy and radiotherapy on the rate of recurrence of pigmented villonodular synovitis of the knee: an individual patient meta-analysis. Bone Joint J. 2015 Apr;97-B(4):550-7. | CrossRef | PubMed |

Bickels J, Isaakov J, Kollender Y, Meller I. Unacceptable complications following intra-articular injection of yttrium 90 in the ankle joint for diffuse pigmented villonodular synovitis. J Bone Joint Surg Am. 2008 Feb;90(2):326-8. | CrossRef | PubMed |

Brahmi M, Vinceneux A, Cassier PA. Current Systemic Treatment Options for Tenosynovial Giant Cell Tumor/Pigmented Villonodular Synovitis: Targeting the CSF1/CSF1R Axis. Curr Treat Options Oncol. 2016 Feb;17(2):10. | CrossRef | PubMed |

Peyraud F, Cousin S, Italiano A. CSF-1R Inhibitor Development: Current Clinical Status. Curr Oncol Rep. 2017 Sep 5;19(11):70. | CrossRef | PubMed |

Castro Corredor D, Bravo WRM, Huaranga MAR, Mateos Rodríguez JJ, Rebollo Giménez AI, Anino Fernández J, et al. Radioisotope Synoviorthesis in the Control of Refractory Synovitis in Castilla-La Mancha. A 10-year Experience. Reumatol Clin. 2019 Jan 25. pii: S1699-258X(18)30238-9. | CrossRef | PubMed |